These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 9207792

  • 1. Correlation between severity and SMN protein level in spinal muscular atrophy.
    Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J.
    Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792
    [Abstract] [Full Text] [Related]

  • 2. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E, Baiget M.
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [Abstract] [Full Text] [Related]

  • 3. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.
    Bouhouche A, Benomar A, Birouk N, Bouslam N, Ouazzani R, Yahyaoui M, Chkili T.
    J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604
    [Abstract] [Full Text] [Related]

  • 4. SMN oligomerization defect correlates with spinal muscular atrophy severity.
    Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, Le T, Burghes AH, Androphy EJ.
    Nat Genet; 1998 May; 19(1):63-6. PubMed ID: 9590291
    [Abstract] [Full Text] [Related]

  • 5. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B.
    Hum Mutat; 2000 May; 15(3):228-37. PubMed ID: 10679938
    [Abstract] [Full Text] [Related]

  • 6. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M, Majumdar R, Al-Rajeh S, Awada A, Chaves-Carbello E, Salih M, Al-Shahwan S, Al-Subiey K, Al-Uthaim S.
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [Abstract] [Full Text] [Related]

  • 7. Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology.
    Anderson K, Potter A, Baban D, Davies KE.
    Brain; 2003 Sep; 126(Pt 9):2052-64. PubMed ID: 12847076
    [Abstract] [Full Text] [Related]

  • 8. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy.
    Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, Davies KE, Mathew CG.
    Eur J Hum Genet; 1998 Sep; 6(5):467-74. PubMed ID: 9801871
    [Abstract] [Full Text] [Related]

  • 9. NAIP-deletion analysis in Malaysian patients with spinal muscular atrophy.
    Watihayati MS, Zabidi AM, Tang TH, Nishio H, Zilfalil BA.
    Kobe J Med Sci; 2007 Sep; 53(4):171-5. PubMed ID: 17932457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy.
    Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y.
    Nature; 1997 Nov 27; 390(6658):413-7. PubMed ID: 9389483
    [Abstract] [Full Text] [Related]

  • 12. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B, Mas C, Giudicelli C, Nepote V, Guimiot F, Levacher B, Zvara A, Santha M, LeGall I, Simonneau M.
    Eur J Hum Genet; 2004 Sep 27; 12(9):729-37. PubMed ID: 15162126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J.
    J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293
    [Abstract] [Full Text] [Related]

  • 16. A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients.
    Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Bürglen L, Cruaud C, Urtizberea JA, Colomer J, Munnich A, Baiget M.
    Nat Genet; 1995 Nov 14; 11(3):335-7. PubMed ID: 7581461
    [Abstract] [Full Text] [Related]

  • 17. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, Scheffer H, Wokke JH, Van den Berg LH.
    Neurology; 2005 Sep 27; 65(6):820-5. PubMed ID: 16093455
    [Abstract] [Full Text] [Related]

  • 18. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit.
    Anderson KN, Baban D, Oliver PL, Potter A, Davies KE.
    Neuromuscul Disord; 2004 Nov 27; 14(11):711-22. PubMed ID: 15482955
    [Abstract] [Full Text] [Related]

  • 19. Neuronal-specific roles of the survival motor neuron protein: evidence from survival motor neuron expression patterns in the developing human central nervous system.
    Giavazzi A, Setola V, Simonati A, Battaglia G.
    J Neuropathol Exp Neurol; 2006 Mar 27; 65(3):267-77. PubMed ID: 16651888
    [Abstract] [Full Text] [Related]

  • 20. Refined characterization of the expression and stability of the SMN gene products.
    Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, Brahe C, Saugier-Veber P, Bonnefont JP, Melki J.
    Am J Pathol; 2007 Oct 27; 171(4):1269-80. PubMed ID: 17717146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.